papers/abateDistinctViralMutational2015a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, BL Tier 1,
27 27
This study, New Tier 2, 1
28 28
New Tier 2, BL Tier 2, 1
29
-Other studies, BL Tier 1, 29
30
-Other studies, BL Tier 2, 156
29
+All other BL studies, BL Tier 1, 29
30
+All other BL studies, BL Tier 2, 156
31 31
```
32 32
33 33
papers/albuquerqueEnhancingKnowledgeDiscovery2017a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 3
26 26
New Tier 1, DLBCL Tier 1, 3
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 125
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 125
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/arthurGenomewideDiscoverySomatic2018.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 8
26 26
New Tier 1, DLBCL Tier 1, 8
27 27
This study, New Tier 2, 12
28 28
New Tier 2, DLBCL Tier 2, 12
29
-Other studies, DLBCL Tier 1, 120
30
-Other studies, DLBCL Tier 2, 186
29
+All other DLBCL studies, DLBCL Tier 1, 120
30
+All other DLBCL studies, DLBCL Tier 2, 186
31 31
```
32 32
33 33
papers/barariaCathepsinAlterationsInduce2020c.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, FL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, FL Tier 2,
29
-Other studies, FL Tier 1, 65
30
-Other studies, FL Tier 2, 50
29
+All other FL studies, FL Tier 1, 65
30
+All other FL studies, FL Tier 2, 50
31 31
```
32 32
33 33
papers/beaLandscapeSomaticMutations2013.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 11
26 26
New Tier 1, MCL Tier 1, 11
27 27
This study, New Tier 2, 16
28 28
New Tier 2, MCL Tier 2, 16
29
-Other studies, MCL Tier 1, 12
30
-Other studies, MCL Tier 2, 30
29
+All other MCL studies, MCL Tier 1, 12
30
+All other MCL studies, MCL Tier 2, 30
31 31
```
32 32
33 33
papers/bohleRoleEarlyBcell2013.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/braggioGenomicAnalysisMarginal2012.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, MZL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, MZL Tier 2,
29
-Other studies, MZL Tier 1, 41
30
-Other studies, MZL Tier 2, 74
29
+All other MZL studies, MZL Tier 1, 41
30
+All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33 33
papers/burkhardtClinicalRelevanceMolecular2022b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, BL Tier 1,
27 27
This study, New Tier 2, 25
28 28
New Tier 2, BL Tier 2, 25
29
-Other studies, BL Tier 1, 29
30
-Other studies, BL Tier 2, 132
29
+All other BL studies, BL Tier 1, 29
30
+All other BL studies, BL Tier 2, 132
31 31
```
32 32
33 33
papers/chapuyMolecularSubtypesDiffuse2018b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, DLBCL Tier 1, 2
27 27
This study, New Tier 2, 17
28 28
New Tier 2, DLBCL Tier 2, 17
29
-Other studies, DLBCL Tier 1, 126
30
-Other studies, DLBCL Tier 2, 181
29
+All other DLBCL studies, DLBCL Tier 1, 126
30
+All other DLBCL studies, DLBCL Tier 2, 181
31 31
```
32 32
33 33
papers/cheungAcquiredTNFRSF14Mutations2010a.md
... ...
@@ -24,11 +24,11 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, DLBCL Tier 1, 1
27
+New Tier 1, FL Tier 1, 1
28 28
This study, New Tier 2,
29
-New Tier 2, DLBCL Tier 2,
30
-Other studies, DLBCL Tier 1, 127
31
-Other studies, DLBCL Tier 2, 198
29
+New Tier 2, FL Tier 2,
30
+All other FL studies, FL Tier 1, 65
31
+All other FL studies, FL Tier 2, 50
32 32
```
33 33
34 34
papers/compagnoMutationsMultipleGenes2009a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/deschGenotypingCirculatingTumor2020.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2, 9
28 28
New Tier 2, PMBL Tier 2, 9
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 73
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 73
31 31
```
32 32
33 33
papers/dunsCharacterizationDLBCLPMBL2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|8|3|
12 11
|PMBL|6|8|
12
+|DLBCL|8|3|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -27,29 +27,29 @@ This study, New Tier 1, 6
27 27
New Tier 1, PMBL Tier 1, 6
28 28
This study, New Tier 2, 8
29 29
New Tier 2, PMBL Tier 2, 8
30
-Other studies, PMBL Tier 1, 70
31
-Other studies, PMBL Tier 2, 74
30
+All other PMBL studies, PMBL Tier 1, 70
31
+All other PMBL studies, PMBL Tier 2, 74
32 32
```
33 33
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|DLBCL tier|PMBL tier|
37
+|New gene|PMBL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39 39
|[BIRC3](BIRC3)|2 |2 |
40 40
|[CD83](CD83)|1 |1 |
41 41
|[CREBBP](CREBBP)|1 |1 |
42 42
|[DUSP2](DUSP2)|1 |1 |
43
-|[FOXO1](FOXO1)|1 |2 |
44
-|[HRNR](HRNR)| |2 |
43
+|[FOXO1](FOXO1)|2 |1 |
44
+|[HRNR](HRNR)|2 | |
45 45
|[IL4R](IL4R)|1 |1 |
46
-|[LPHN3](LPHN3)| |2 |
46
+|[LPHN3](LPHN3)|2 | |
47 47
|[MCL1](MCL1)|2 |2 |
48
-|[MYC](MYC)|1 |2 |
48
+|[MYC](MYC)|2 |1 |
49 49
|[PIM1](PIM1)|1 |1 |
50 50
|[RFTN1](RFTN1)|2 |2 |
51 51
|[SGK1](SGK1)|1 |1 |
52
-|[WDR87](WDR87)| |2 |
52
+|[WDR87](WDR87)|2 | |
53 53
54 54
# Details
55 55
papers/ganapathiGeneticLandscapeDural2016.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, MZL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, MZL Tier 2,
29
-Other studies, MZL Tier 1, 41
30
-Other studies, MZL Tier 2, 74
29
+All other MZL studies, MZL Tier 1, 41
30
+All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33 33
papers/gomezUltraDeepSequencingReveals2023.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, PMBL Tier 1, 2
27 27
This study, New Tier 2, 5
28 28
New Tier 2, PMBL Tier 2, 5
29
-Other studies, PMBL Tier 1, 74
30
-Other studies, PMBL Tier 2, 77
29
+All other PMBL studies, PMBL Tier 1, 74
30
+All other PMBL studies, PMBL Tier 2, 77
31 31
```
32 32
33 33
papers/grandeGenomewideDiscoverySomatic2019.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 9
26 26
New Tier 1, BL Tier 1, 9
27 27
This study, New Tier 2, 4
28 28
New Tier 2, BL Tier 2, 4
29
-Other studies, BL Tier 1, 20
30
-Other studies, BL Tier 2, 153
29
+All other BL studies, BL Tier 1, 20
30
+All other BL studies, BL Tier 2, 153
31 31
```
32 32
33 33
papers/gunawardanaRecurrentSomaticMutations2014c.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/hubschmannMutationalMechanismsShaping2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|3|23|
12 11
|FL|2|15|
12
+|DLBCL|3|23|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -27,53 +27,53 @@ This study, New Tier 1, 3
27 27
New Tier 1, DLBCL Tier 1, 3
28 28
This study, New Tier 2, 23
29 29
New Tier 2, DLBCL Tier 2, 23
30
-Other studies, DLBCL Tier 1, 125
31
-Other studies, DLBCL Tier 2, 175
30
+All other DLBCL studies, DLBCL Tier 1, 125
31
+All other DLBCL studies, DLBCL Tier 2, 175
32 32
```
33 33
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|DLBCL tier|FL tier|
37
+|New gene|FL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[ACTG1](ACTG1)|1 |2 |
40
-|[ADAMTS1](ADAMTS1)|2 | |
41
-|[ANKRD12](ANKRD12)|2 | |
42
-|[ATP6V1A](ATP6V1A)| |2 |
43
-|[CADPS2](CADPS2)|2 | |
44
-|[CCDC42BPB](CCDC42BPB)| |2 |
45
-|[CNOT2](CNOT2)|2 | |
46
-|[CPNE8](CPNE8)| |2 |
47
-|[DHX15](DHX15)| |2 |
48
-|[DHX16](DHX16)|2 | |
49
-|[DNM2](DNM2)|2 | |
39
+|[ACTG1](ACTG1)|2 |1 |
40
+|[ADAMTS1](ADAMTS1)| |2 |
41
+|[ANKRD12](ANKRD12)| |2 |
42
+|[ATP6V1A](ATP6V1A)|2 | |
43
+|[CADPS2](CADPS2)| |2 |
44
+|[CCDC42BPB](CCDC42BPB)|2 | |
45
+|[CNOT2](CNOT2)| |2 |
46
+|[CPNE8](CPNE8)|2 | |
47
+|[DHX15](DHX15)|2 | |
48
+|[DHX16](DHX16)| |2 |
49
+|[DNM2](DNM2)| |2 |
50 50
|[EEF1A1](EEF1A1)|1 |1 |
51
-|[FBXO11](FBXO11)|1 | |
52
-|[FZR1](FZR1)| |2 |
53
-|[GAK](GAK)|2 | |
54
-|[HLA-DQA1](HLA-DQA1)|2 | |
55
-|[IKBKE](IKBKE)|2 | |
56
-|[IRF1](IRF1)|2 | |
57
-|[JUP](JUP)| |2 |
51
+|[FBXO11](FBXO11)| |1 |
52
+|[FZR1](FZR1)|2 | |
53
+|[GAK](GAK)| |2 |
54
+|[HLA-DQA1](HLA-DQA1)| |2 |
55
+|[IKBKE](IKBKE)| |2 |
56
+|[IRF1](IRF1)| |2 |
57
+|[JUP](JUP)|2 | |
58 58
|[LAPTM5](LAPTM5)|2 |2 |
59
-|[LRP12](LRP12)|2 | |
60
-|[MGEA5](MGEA5)| |2 |
61
-|[MYCBP2](MYCBP2)| |2 |
62
-|[N2RF2](N2RF2)|2 | |
59
+|[LRP12](LRP12)| |2 |
60
+|[MGEA5](MGEA5)|2 | |
61
+|[MYCBP2](MYCBP2)|2 | |
62
+|[N2RF2](N2RF2)| |2 |
63 63
|[PDS5B](PDS5B)|2 |2 |
64
-|[PNPO](PNPO)|2 | |
65
-|[PPP4C](PPP4C)| |2 |
64
+|[PNPO](PNPO)| |2 |
65
+|[PPP4C](PPP4C)|2 | |
66 66
|[PRKDC](PRKDC)|2 |2 |
67
-|[RAC2](RAC2)|2 | |
68
-|[RBM6](RBM6)| |2 |
69
-|[SIAH2](SIAH2)|2 | |
70
-|[SLC34A2](SLC34A2)|2 | |
71
-|[TPP1](TPP1)| |2 |
72
-|[TRAF6](TRAF6)|2 | |
73
-|[UNC5B](UNC5B)|2 | |
74
-|[VMA21](VMA21)| |1 |
75
-|[WNK1](WNK1)|2 | |
76
-|[ZNF217](ZNF217)|2 | |
67
+|[RAC2](RAC2)| |2 |
68
+|[RBM6](RBM6)|2 | |
69
+|[SIAH2](SIAH2)| |2 |
70
+|[SLC34A2](SLC34A2)| |2 |
71
+|[TPP1](TPP1)|2 | |
72
+|[TRAF6](TRAF6)| |2 |
73
+|[UNC5B](UNC5B)| |2 |
74
+|[VMA21](VMA21)|1 | |
75
+|[WNK1](WNK1)| |2 |
76
+|[ZNF217](ZNF217)| |2 |
77 77
78 78
# Details
79 79
papers/jalladesExomeSequencingIdentifies2017.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, MZL Tier 1, 2
27 27
This study, New Tier 2, 26
28 28
New Tier 2, MZL Tier 2, 26
29
-Other studies, MZL Tier 1, 40
30
-Other studies, MZL Tier 2, 48
29
+All other MZL studies, MZL Tier 1, 40
30
+All other MZL studies, MZL Tier 2, 48
31 31
```
32 32
33 33
papers/jardinRecurrentMutationsExportin2016a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/johnstonCmycHypermutationBurkitt1992.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, BL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, BL Tier 2,
29
-Other studies, BL Tier 1, 28
30
-Other studies, BL Tier 2, 157
29
+All other BL studies, BL Tier 1, 28
30
+All other BL studies, BL Tier 2, 157
31 31
```
32 32
33 33
papers/khodabakhshiRecurrentTargetsAberrant2012.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/krysiakRecurrentSomaticMutations2017b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 17
26 26
New Tier 1, FL Tier 1, 17
27 27
This study, New Tier 2, 5
28 28
New Tier 2, FL Tier 2, 5
29
-Other studies, FL Tier 1, 49
30
-Other studies, FL Tier 2, 45
29
+All other FL studies, FL Tier 1, 49
30
+All other FL studies, FL Tier 2, 45
31 31
```
32 32
33 33
papers/kwanhianMicroRNA142Mutated202012b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, DLBCL Tier 1,
27 27
This study, New Tier 2, 1
28 28
New Tier 2, DLBCL Tier 2, 1
29
-Other studies, DLBCL Tier 1, 128
30
-Other studies, DLBCL Tier 2, 197
29
+All other DLBCL studies, DLBCL Tier 1, 128
30
+All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33 33
papers/lakeMutationsNFKBIAEncoding2009.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/lenzOncogenicCARD11Mutations2008.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/lohrDiscoveryPrioritizationSomatic2012a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 3
26 26
New Tier 1, DLBCL Tier 1, 3
27 27
This study, New Tier 2, 1
28 28
New Tier 2, DLBCL Tier 2, 1
29
-Other studies, DLBCL Tier 1, 125
30
-Other studies, DLBCL Tier 2, 197
29
+All other DLBCL studies, DLBCL Tier 1, 125
30
+All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33 33
papers/louissaintPediatrictypeNodalFollicular2016a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, FL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, FL Tier 2,
29
-Other studies, FL Tier 1, 65
30
-Other studies, FL Tier 2, 50
29
+All other FL studies, FL Tier 1, 65
30
+All other FL studies, FL Tier 2, 50
31 31
```
32 32
33 33
papers/loveGeneticLandscapeMutations2012.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 3
26 26
New Tier 1, BL Tier 1, 3
27 27
This study, New Tier 2, 56
28 28
New Tier 2, BL Tier 2, 56
29
-Other studies, BL Tier 1, 26
30
-Other studies, BL Tier 2, 101
29
+All other BL studies, BL Tier 1, 26
30
+All other BL studies, BL Tier 2, 101
31 31
```
32 32
33 33
papers/mansouriFrequentNFKBIEDeletions2016.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/mareschalWholeExomeSequencing2016.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, DLBCL Tier 1, 2
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 126
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 126
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/morinFrequentMutationHistonemodifying2011.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|27|1|
12 11
|FL|19|4|
12
+|DLBCL|27|1|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -27,29 +27,29 @@ This study, New Tier 1, 27
27 27
New Tier 1, DLBCL Tier 1, 27
28 28
This study, New Tier 2, 1
29 29
New Tier 2, DLBCL Tier 2, 1
30
-Other studies, DLBCL Tier 1, 101
31
-Other studies, DLBCL Tier 2, 197
30
+All other DLBCL studies, DLBCL Tier 1, 101
31
+All other DLBCL studies, DLBCL Tier 2, 197
32 32
```
33 33
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|DLBCL tier|FL tier|
37
+|New gene|FL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39 39
|[B2M](B2M)|1 |1 |
40
-|[BCL10](BCL10)|1 |2 |
40
+|[BCL10](BCL10)|2 |1 |
41 41
|[BCL2](BCL2)|1 |1 |
42 42
|[BCL6](BCL6)|1 |1 |
43 43
|[BTG1](BTG1)|1 |1 |
44 44
|[BTG2](BTG2)|1 |1 |
45 45
|[CARD11](CARD11)|1 |1 |
46 46
|[CCND3](CCND3)|1 |1 |
47
-|[CD274](CD274)|2 | |
48
-|[CD58](CD58)|1 | |
49
-|[CD70](CD70)|1 |2 |
50
-|[CD79B](CD79B)|1 |2 |
51
-|[CIITA](CIITA)|1 | |
52
-|[ETS1](ETS1)|1 | |
47
+|[CD274](CD274)| |2 |
48
+|[CD58](CD58)| |1 |
49
+|[CD70](CD70)|2 |1 |
50
+|[CD79B](CD79B)|2 |1 |
51
+|[CIITA](CIITA)| |1 |
52
+|[ETS1](ETS1)| |1 |
53 53
|[FOXO1](FOXO1)|1 |1 |
54 54
|[GNA13](GNA13)|1 |1 |
55 55
|[HIST1H1C](HIST1H1C)|1 |1 |
... ...
@@ -61,9 +61,9 @@ Other studies, DLBCL Tier 2, 197
61 61
|[S1PR2](S1PR2)|1 |1 |
62 62
|[SGK1](SGK1)|1 |1 |
63 63
|[SOCS1](SOCS1)|1 |1 |
64
-|[TMEM30A](TMEM30A)|1 |2 |
64
+|[TMEM30A](TMEM30A)|2 |1 |
65 65
|[TP53](TP53)|1 |1 |
66
-|[ZFP36L1](ZFP36L1)|1 | |
66
+|[ZFP36L1](ZFP36L1)| |1 |
67 67
68 68
# Details
69 69
papers/morinGeneticLandscapesRelapsed2016.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, DLBCL Tier 1, 2
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 126
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 126
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/morinMutationalStructuralAnalysis2013.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 11
26 26
New Tier 1, DLBCL Tier 1, 11
27 27
This study, New Tier 2, 29
28 28
New Tier 2, DLBCL Tier 2, 29
29
-Other studies, DLBCL Tier 1, 117
30
-Other studies, DLBCL Tier 2, 169
29
+All other DLBCL studies, DLBCL Tier 1, 117
30
+All other DLBCL studies, DLBCL Tier 2, 169
31 31
```
32 32
33 33
papers/morinSomaticMutationsAltering2010a.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|FL|1||
12 11
|DLBCL|1||
12
+|FL|1||
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -24,17 +24,17 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, FL Tier 1, 1
27
+New Tier 1, DLBCL Tier 1, 1
28 28
This study, New Tier 2,
29
-New Tier 2, FL Tier 2,
30
-Other studies, FL Tier 1, 65
31
-Other studies, FL Tier 2, 50
29
+New Tier 2, DLBCL Tier 2,
30
+All other DLBCL studies, DLBCL Tier 1, 127
31
+All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|FL tier|DLBCL tier|
37
+|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39 39
|[EZH2](EZH2)|1 |1 |
40 40
papers/mottokGenomicAlterationsCIITA2015b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/mottokIntegrativeGenomicAnalysis2019b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 6
26 26
New Tier 1, PMBL Tier 1, 6
27 27
This study, New Tier 2, 15
28 28
New Tier 2, PMBL Tier 2, 15
29
-Other studies, PMBL Tier 1, 70
30
-Other studies, PMBL Tier 2, 67
29
+All other PMBL studies, PMBL Tier 1, 70
30
+All other PMBL studies, PMBL Tier 2, 67
31 31
```
32 32
33 33
papers/muppidiLossSignalingGa132014b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, BL Tier 1, 1
27 27
This study, New Tier 2, 2
28 28
New Tier 2, BL Tier 2, 2
29
-Other studies, BL Tier 1, 28
30
-Other studies, BL Tier 2, 155
29
+All other BL studies, BL Tier 1, 28
30
+All other BL studies, BL Tier 2, 155
31 31
```
32 32
33 33
papers/nadeuGenomicEpigenomicInsights2020b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 3
26 26
New Tier 1, MCL Tier 1, 3
27 27
This study, New Tier 2, 2
28 28
New Tier 2, MCL Tier 2, 2
29
-Other studies, MCL Tier 1, 20
30
-Other studies, MCL Tier 2, 44
29
+All other MCL studies, MCL Tier 1, 20
30
+All other MCL studies, MCL Tier 2, 44
31 31
```
32 32
33 33
papers/ngoOncogenicallyActiveMYD882011a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/ohgamiSTAT3MutationsAre2014.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/okosunRecurrentMTORC1activatingRRAGC2016a.md
... ...
@@ -27,8 +27,8 @@ This study, New Tier 1, 3
27 27
New Tier 1, FL Tier 1, 3
28 28
This study, New Tier 2,
29 29
New Tier 2, FL Tier 2,
30
-Other studies, FL Tier 1, 63
31
-Other studies, FL Tier 2, 50
30
+All other FL studies, FL Tier 1, 63
31
+All other FL studies, FL Tier 2, 50
32 32
```
33 33
34 34
papers/oricchioGeneticEpigeneticInactivation2017b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, FL Tier 1,
27 27
This study, New Tier 2, 1
28 28
New Tier 2, FL Tier 2, 1
29
-Other studies, FL Tier 1, 66
30
-Other studies, FL Tier 2, 49
29
+All other FL studies, FL Tier 1, 66
30
+All other FL studies, FL Tier 2, 49
31 31
```
32 32
33 33
papers/ottoGeneticLesionsTRAF32012a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, PMBL Tier 1, 2
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 74
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 74
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/paneaWholeGenomeLandscape2019.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 4
26 26
New Tier 1, BL Tier 1, 4
27 27
This study, New Tier 2, 46
28 28
New Tier 2, BL Tier 2, 46
29
-Other studies, BL Tier 1, 25
30
-Other studies, BL Tier 2, 111
29
+All other BL studies, BL Tier 1, 25
30
+All other BL studies, BL Tier 2, 111
31 31
```
32 32
33 33
papers/pararajalingamCodingNoncodingDrivers2020.md
... ...
@@ -27,8 +27,8 @@ This study, New Tier 1, 6
27 27
New Tier 1, MCL Tier 1, 6
28 28
This study, New Tier 2, 1
29 29
New Tier 2, MCL Tier 2, 1
30
-Other studies, MCL Tier 1, 17
31
-Other studies, MCL Tier 2, 45
30
+All other MCL studies, MCL Tier 1, 17
31
+All other MCL studies, MCL Tier 2, 45
32 32
```
33 33
34 34
papers/parryWholeExomeSequencing2013.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|3|1|
12 11
|MZL||8|
12
+|DLBCL|3|1|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -27,23 +27,23 @@ This study, New Tier 1,
27 27
New Tier 1, MZL Tier 1,
28 28
This study, New Tier 2, 8
29 29
New Tier 2, MZL Tier 2, 8
30
-Other studies, MZL Tier 1, 42
31
-Other studies, MZL Tier 2, 66
30
+All other MZL studies, MZL Tier 1, 42
31
+All other MZL studies, MZL Tier 2, 66
32 32
```
33 33
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|DLBCL tier|MZL tier|
37
+|New gene|MZL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[AMOTL1](AMOTL1)| |2 |
40
-|[CBFA2T3](CBFA2T3)| |2 |
41
-|[CREBBP](CREBBP)|1 |2 |
39
+|[AMOTL1](AMOTL1)|2 | |
40
+|[CBFA2T3](CBFA2T3)|2 | |
41
+|[CREBBP](CREBBP)|2 |1 |
42 42
|[FAT4](FAT4)|2 |2 |
43
-|[FBXO11](FBXO11)|1 |2 |
44
-|[PLA2G4D](PLA2G4D)| |2 |
45
-|[TRRAP](TRRAP)|1 |2 |
46
-|[USH2A](USH2A)| |2 |
43
+|[FBXO11](FBXO11)|2 |1 |
44
+|[PLA2G4D](PLA2G4D)|2 | |
45
+|[TRRAP](TRRAP)|2 |1 |
46
+|[USH2A](USH2A)|2 | |
47 47
48 48
# Details
49 49
papers/pasqualucciAnalysisCodingGenome2011.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 3
26 26
New Tier 1, DLBCL Tier 1, 3
27 27
This study, New Tier 2, 4
28 28
New Tier 2, DLBCL Tier 2, 4
29
-Other studies, DLBCL Tier 1, 125
30
-Other studies, DLBCL Tier 2, 194
29
+All other DLBCL studies, DLBCL Tier 1, 125
30
+All other DLBCL studies, DLBCL Tier 2, 194
31 31
```
32 32
33 33
papers/pasqualucciHypermutationMultipleProtooncogenes2001a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, DLBCL Tier 1, 2
27 27
This study, New Tier 2, 2
28 28
New Tier 2, DLBCL Tier 2, 2
29
-Other studies, DLBCL Tier 1, 126
30
-Other studies, DLBCL Tier 2, 196
29
+All other DLBCL studies, DLBCL Tier 1, 126
30
+All other DLBCL studies, DLBCL Tier 2, 196
31 31
```
32 32
33 33
papers/pasqualucciInactivatingMutationsAcetyltransferase2011a.md
... ...
@@ -27,8 +27,8 @@ This study, New Tier 1, 2
27 27
New Tier 1, FL Tier 1, 2
28 28
This study, New Tier 2,
29 29
New Tier 2, FL Tier 2,
30
-Other studies, FL Tier 1, 64
31
-Other studies, FL Tier 2, 50
30
+All other FL studies, FL Tier 1, 64
31
+All other FL studies, FL Tier 2, 50
32 32
```
33 33
34 34
papers/pasqualucciInactivationPRDM1BLIMP12006a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/reddyGeneticFunctionalDrivers2017.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 7
26 26
New Tier 1, DLBCL Tier 1, 7
27 27
This study, New Tier 2, 53
28 28
New Tier 2, DLBCL Tier 2, 53
29
-Other studies, DLBCL Tier 1, 121
30
-Other studies, DLBCL Tier 2, 145
29
+All other DLBCL studies, DLBCL Tier 1, 121
30
+All other DLBCL studies, DLBCL Tier 2, 145
31 31
```
32 32
33 33
papers/reichelFlowSortingExome2015a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 11
26 26
New Tier 1, PMBL Tier 1, 11
27 27
This study, New Tier 2, 18
28 28
New Tier 2, PMBL Tier 2, 18
29
-Other studies, PMBL Tier 1, 65
30
-Other studies, PMBL Tier 2, 64
29
+All other PMBL studies, PMBL Tier 1, 65
30
+All other PMBL studies, PMBL Tier 2, 64
31 31
```
32 32
33 33
papers/richterRecurrentMutationID32012a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 5
26 26
New Tier 1, BL Tier 1, 5
27 27
This study, New Tier 2,
28 28
New Tier 2, BL Tier 2,
29
-Other studies, BL Tier 1, 24
30
-Other studies, BL Tier 2, 157
29
+All other BL studies, BL Tier 1, 24
30
+All other BL studies, BL Tier 2, 157
31 31
```
32 32
33 33
papers/ritzRecurrentMutationsSTAT62009a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/rossiAlterationBIRC3Multiple2011a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 4
26 26
New Tier 1, MZL Tier 1, 4
27 27
This study, New Tier 2, 1
28 28
New Tier 2, MZL Tier 2, 1
29
-Other studies, MZL Tier 1, 38
30
-Other studies, MZL Tier 2, 73
29
+All other MZL studies, MZL Tier 1, 38
30
+All other MZL studies, MZL Tier 2, 73
31 31
```
32 32
33 33
papers/rossiCodingGenomeSplenic2012c.md
... ...
@@ -27,8 +27,8 @@ This study, New Tier 1, 10
27 27
New Tier 1, MZL Tier 1, 10
28 28
This study, New Tier 2, 11
29 29
New Tier 2, MZL Tier 2, 11
30
-Other studies, MZL Tier 1, 32
31
-Other studies, MZL Tier 2, 63
30
+All other MZL studies, MZL Tier 1, 32
31
+All other MZL studies, MZL Tier 2, 63
32 32
```
33 33
34 34
papers/rushtonGeneticEvolutionaryPatterns2020.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/russler-germainMutationsAssociatedProgression2023b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, FL Tier 1, 1
27 27
This study, New Tier 2, 19
28 28
New Tier 2, FL Tier 2, 19
29
-Other studies, FL Tier 1, 65
30
-Other studies, FL Tier 2, 31
29
+All other FL studies, FL Tier 1, 65
30
+All other FL studies, FL Tier 2, 31
31 31
```
32 32
33 33
papers/sarkozyMutationalLandscapeGray2021a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 5
26 26
New Tier 1, PMBL Tier 1, 5
27 27
This study, New Tier 2, 6
28 28
New Tier 2, PMBL Tier 2, 6
29
-Other studies, PMBL Tier 1, 71
30
-Other studies, PMBL Tier 2, 76
29
+All other PMBL studies, PMBL Tier 1, 71
30
+All other PMBL studies, PMBL Tier 2, 76
31 31
```
32 32
33 33
papers/schmitzBurkittLymphomaPathogenesis2012.md
... ...
@@ -27,8 +27,8 @@ This study, New Tier 1, 4
27 27
New Tier 1, BL Tier 1, 4
28 28
This study, New Tier 2, 16
29 29
New Tier 2, BL Tier 2, 16
30
-Other studies, BL Tier 1, 25
31
-Other studies, BL Tier 2, 141
30
+All other BL studies, BL Tier 1, 25
31
+All other BL studies, BL Tier 2, 141
32 32
```
33 33
34 34
papers/schmitzGeneticsPathogenesisDiffuse2018a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 7
26 26
New Tier 1, DLBCL Tier 1, 7
27 27
This study, New Tier 2, 9
28 28
New Tier 2, DLBCL Tier 2, 9
29
-Other studies, DLBCL Tier 1, 121
30
-Other studies, DLBCL Tier 2, 189
29
+All other DLBCL studies, DLBCL Tier 1, 121
30
+All other DLBCL studies, DLBCL Tier 2, 189
31 31
```
32 32
33 33
papers/schmitzTNFAIP3A20Tumor2009a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/schneiderAlterationsCD58Gene2015a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/schollMutationsRegionFAS2007.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/shinBRAFV600EMAP2K12015.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, DLBCL Tier 1,
27 27
This study, New Tier 2, 1
28 28
New Tier 2, DLBCL Tier 2, 1
29
-Other studies, DLBCL Tier 1, 128
30
-Other studies, DLBCL Tier 2, 197
29
+All other DLBCL studies, DLBCL Tier 1, 128
30
+All other DLBCL studies, DLBCL Tier 2, 197
31 31
```
32 32
33 33
papers/spinaGeneticsNodalMarginal2016b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 8
26 26
New Tier 1, MZL Tier 1, 8
27 27
This study, New Tier 2, 23
28 28
New Tier 2, MZL Tier 2, 23
29
-Other studies, MZL Tier 1, 34
30
-Other studies, MZL Tier 2, 51
29
+All other MZL studies, MZL Tier 1, 34
30
+All other MZL studies, MZL Tier 2, 51
31 31
```
32 32
33 33
papers/tanakaFrequentIncidenceSomatic1992.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/thomasGeneticSubgroupsInform2023.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, BL Tier 1, 2
27 27
This study, New Tier 2, 3
28 28
New Tier 2, BL Tier 2, 3
29
-Other studies, BL Tier 1, 27
30
-Other studies, BL Tier 2, 154
29
+All other BL studies, BL Tier 1, 27
30
+All other BL studies, BL Tier 2, 154
31 31
```
32 32
33 33
papers/tiacciBRAFMutationsHairycell2011a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/tiacciPervasiveMutationsJAKSTAT2018b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2, 9
28 28
New Tier 2, PMBL Tier 2, 9
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 73
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 73
31 31
```
32 32
33 33
papers/troenNOTCH2MutationsMarginal2008.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, DLBCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, DLBCL Tier 2,
29
-Other studies, DLBCL Tier 1, 127
30
-Other studies, DLBCL Tier 2, 198
29
+All other DLBCL studies, DLBCL Tier 1, 127
30
+All other DLBCL studies, DLBCL Tier 2, 198
31 31
```
32 32
33 33
papers/vandenbrandRecurrentMutationsGenes2017.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, MZL Tier 1,
27 27
This study, New Tier 2, 2
28 28
New Tier 2, MZL Tier 2, 2
29
-Other studies, MZL Tier 1, 42
30
-Other studies, MZL Tier 2, 72
29
+All other MZL studies, MZL Tier 1, 42
30
+All other MZL studies, MZL Tier 2, 72
31 31
```
32 32
33 33
papers/viganoSomaticIL4RMutations2018b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, PMBL Tier 2,
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 82
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 82
31 31
```
32 32
33 33
papers/wenigerMutationsTumorSuppressor2006a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, PMBL Tier 1, 1
27 27
This study, New Tier 2, 1
28 28
New Tier 2, PMBL Tier 2, 1
29
-Other studies, PMBL Tier 1, 75
30
-Other studies, PMBL Tier 2, 81
29
+All other PMBL studies, PMBL Tier 1, 75
30
+All other PMBL studies, PMBL Tier 2, 81
31 31
```
32 32
33 33
papers/wienandGenomicAnalysesFlowsorted2019b.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 4
26 26
New Tier 1, PMBL Tier 1, 4
27 27
This study, New Tier 2, 3
28 28
New Tier 2, PMBL Tier 2, 3
29
-Other studies, PMBL Tier 1, 72
30
-Other studies, PMBL Tier 2, 79
29
+All other PMBL studies, PMBL Tier 1, 72
30
+All other PMBL studies, PMBL Tier 2, 79
31 31
```
32 32
33 33
papers/wildaInactivationARFMDM2p53Pathway2004.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, BL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, BL Tier 2,
29
-Other studies, BL Tier 1, 28
30
-Other studies, BL Tier 2, 157
29
+All other BL studies, BL Tier 1, 28
30
+All other BL studies, BL Tier 2, 157
31 31
```
32 32
33 33
papers/wuGeneticHeterogeneityPrimary2016.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 1
26 26
New Tier 1, MCL Tier 1, 1
27 27
This study, New Tier 2,
28 28
New Tier 2, MCL Tier 2,
29
-Other studies, MCL Tier 1, 22
30
-Other studies, MCL Tier 2, 46
29
+All other MCL studies, MCL Tier 1, 22
30
+All other MCL studies, MCL Tier 2, 46
31 31
```
32 32
33 33
papers/yanBCRTLRSignaling2012a.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, MZL Tier 1, 2
27 27
This study, New Tier 2,
28 28
New Tier 2, MZL Tier 2,
29
-Other studies, MZL Tier 1, 40
30
-Other studies, MZL Tier 2, 74
29
+All other MZL studies, MZL Tier 1, 40
30
+All other MZL studies, MZL Tier 2, 74
31 31
```
32 32
33 33
papers/yildizActivatingSTAT6Mutations2015c.md
... ...
@@ -24,11 +24,11 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, FL Tier 1, 1
27
+New Tier 1, DLBCL Tier 1, 1
28 28
This study, New Tier 2,
29
-New Tier 2, FL Tier 2,
30
-Other studies, FL Tier 1, 65
31
-Other studies, FL Tier 2, 50
29
+New Tier 2, DLBCL Tier 2,
30
+All other DLBCL studies, DLBCL Tier 1, 127
31
+All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34 34
papers/zhangGeneticHeterogeneityDiffuse2013.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 11
26 26
New Tier 1, DLBCL Tier 1, 11
27 27
This study, New Tier 2, 8
28 28
New Tier 2, DLBCL Tier 2, 8
29
-Other studies, DLBCL Tier 1, 117
30
-Other studies, DLBCL Tier 2, 190
29
+All other DLBCL studies, DLBCL Tier 1, 117
30
+All other DLBCL studies, DLBCL Tier 2, 190
31 31
```
32 32
33 33
papers/zhangGenomicLandscapeMantle2014.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1, 2
26 26
New Tier 1, MCL Tier 1, 2
27 27
This study, New Tier 2, 26
28 28
New Tier 2, MCL Tier 2, 26
29
-Other studies, MCL Tier 1, 21
30
-Other studies, MCL Tier 2, 20
29
+All other MCL studies, MCL Tier 1, 21
30
+All other MCL studies, MCL Tier 2, 20
31 31
```
32 32
33 33
papers/zhouSporadicEndemicBurkitt2019.md
... ...
@@ -26,8 +26,8 @@ This study, New Tier 1,
26 26
New Tier 1, BL Tier 1,
27 27
This study, New Tier 2, 1
28 28
New Tier 2, BL Tier 2, 1
29
-Other studies, BL Tier 1, 29
30
-Other studies, BL Tier 2, 156
29
+All other BL studies, BL Tier 1, 29
30
+All other BL studies, BL Tier 2, 156
31 31
```
32 32
33 33